Start here if you're new
what it is
It helps factories get parts, equipment, and custom components on time, while also making some of the machines and parts themselves.
how it gets paid
Last year Park-Ohio made $1.6B in revenue.
why growth slowed
Revenue fell 3.4% last year. $1.63 EPS mattered because it showed the company can still turn sales into profit.
what just happened
The latest quarter printed $1.63 EPS on $1.2B of revenue.
At a glance
C+ balance sheet — struggling to keep the lights on
15/100 earnings predictability — expect surprises
7.1x trailing p/e — the market's not buying it — or you found a deal
2.0% dividend yield — cash in your pocket every quarter
6.9% return on capital — nothing to write home about
xvary composite: 30/100 — weak
What they do
It helps factories get parts, equipment, and custom components on time, while also making some of the machines and parts themselves.
Park-Ohio lives inside your customer's workflow, not outside it. It does engineering, bar coding, packaging, billing, and just-in-time delivery (parts arrive when needed). With 6,300 employees, replacing it means rebuilding a small chunk of the plant's daily routine.
How they make money
$1.6B
annual revenue · revenue declined -3.4% last year
total revenue
$1.6B
3.4%
The products that matter
supply chain and inventory management
Supply Technologies
$780M · 49% of revenue
it is roughly half the company, and sales still fell 5% in 2025. Here's the thing: when the biggest segment slips, you feel it everywhere.
largest segment
industrial equipment and engineered systems
Engineered Products
$560M · 35% of revenue
this $560M segment was flat in 2025. Management says backlog can drive record 2026 sales. The catch: backlog only matters once it turns into shipped revenue.
backlog bet
aluminum, rubber, and formed components
Assembly Components
$260M · 16% of revenue
it is the smallest segment at $260M, and it still fell 2% in 2025. Smaller does not mean harmless when the company only earned a 4.5% operating margin.
cyclical exposure
Key numbers
7.1x
trailing p/e
Price divided by last year's profit. At 7.1x, you pay $7.10 for $1 of earnings, which is cheap for a reason.
66%
debt load
Long-term debt is 66% of capital. Lenders sit in the room before shareholders do.
2.0%
dividend yield
You get 2.0% back in cash each year. That is income, not a cure for leverage.
7.7%
operating margin
For every $100 of sales, Park-Ohio keeps $7.70 before interest and taxes. The cushion is not thick.
Financial health
C+
strength
- balance sheet grade C+ — weak — may struggle to fund operations
- risk rank 4 — safer than 20% of stocks
- price stability 20 / 100
- long-term debt $691M (66% of capital)
C+ — balance sheet grade and long-term debt are flagged. this stock carries more risk than average.
Total return vs. market
Return history isn't available for PKOH right now.
source: institutional data · return history unavailable
What just happened
beat estimates
The latest quarter printed $1.63 EPS on $1.2B of revenue.
Gross margin was 16.9%. The from a year ago jump was huge, and the consensus estimate field was blank in the source data, so the clean read is profit strength, not a tidy analyst comparison.
$1.2B
revenue
$1.63
eps
16.9%
gross margin
the number that mattered
$1.63 EPS mattered because it showed the company can still turn sales into profit, even with leverage hanging over it.
source: company earnings report, 2026
Get this snapshot in your inbox
This page, delivered free — plus weekly updates when the numbers change. plain english, no spam.
weekly updates
earnings alerts
plain english
no spam
What could go wrong
Park-Ohio does not need a dramatic collapse to disappoint you. It just needs thin margins, uneven demand, and $691M of debt to keep showing up in the same quarter.
med
margin pressure stays stuck
Operating margin was 4.5% in 2025, down from 4.7% in 2024. When margins start this low, even small cost pressure matters.
A one-point margin slip on $1.60B of revenue is roughly $16M of operating income. Against a $352M market cap, that is not background noise.
med
debt keeps driving the equity story
Long-term debt sits at $691M, or 66% of capital. The company reduced debt by $40M in 2025, but the starting point is still heavy for a business with 15/100 earnings predictability.
That does not just raise risk on paper. It cuts into management's room to absorb a weak quarter, invest for growth, and keep the dividend intact at the same time.
med
the 2026 guide does not turn into results
Management is targeting 2026 revenue of $1.675B–$1.710B and leaning on backlog in Engineered Products. If that revenue does not arrive, the stock is just a low-multiple cyclical with unresolved debt pressure.
This is the key contrast in the name: 7.1x earnings looks attractive only if earnings actually recover from the $1.77 reported for 2025.
med
volatility keeps scaring off patient capital
Price stability is 20/100, and the stock traded between $16 and $30 over the last 52 weeks. That is a wide range for a company the market already views cautiously.
If you hold through that kind of swing, you need operating proof to match the volatility. Without it, the discount can stick around longer than you want.
If margin does not improve from 4.5%, if revenue misses the low end of the $1.675B guide, or if debt stops falling from $691M, the recovery case starts looking more like a waiting room than a turnaround.
source: institutional data · regulatory filings · risk analysis
Pay attention to
next earnings
does 4.5% margin finally move
The fastest way to validate the 2026 repair story is simple: operating margin needs to improve from the 4.5% 2025 baseline.
Engineered Products
backlog has to become revenue
Management expects record sales in 2026. If the $560M segment stays flat again, one of the main recovery pillars is missing.
balance sheet
keep score on debt paydown
Debt fell by $40M in 2025. You want to see that direction continue from the current $691M level, not stall after one year of progress.
Supply Technologies
watch the biggest segment first
At $780M, this is 49% of revenue. Another sales decline here would make the rest of the recovery story harder to trust.
Analyst rankings
earnings predictability
15 / 100
in human-speak, analysts do not trust these earnings to land smoothly quarter after quarter.
price stability
20 / 100
The stock has been jumpy. A $16–$30 52-week range tells you the market changes its mind here pretty fast.
risk rank
4
That means safer than roughly 20% of stocks, not 80%. You are not buying a defensive industrial here.
source: institutional data
Institutional activity
institutional ownership data for PKOH is being compiled.
source: institutional data
Price targets
3-5 year target range
n/a
n/a
$23
current price
n/a
target midpoint · n/a from current
Want the deeper analysis?
The full deep dive: dcf model, scenario analysis, competitive moat breakdown, and quarterly tracking — everything on this page, taken further.
see plans from $5/moThe deep dive